Rankings
▼
Calendar
BCYC FY 2024 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$374M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
+30.8% YoY
Gross Profit
-$138M
-390.3% margin
Operating Income
-$210M
-595.0% margin
Net Income
-$169M
-479.2% margin
EPS (Diluted)
$-2.90
Cash Flow
Operating Cash Flow
-$165M
Free Cash Flow
-$166M
Stock-Based Comp.
$38M
Balance Sheet
Total Assets
$957M
Total Liabilities
$164M
Stockholders' Equity
$793M
Cash & Equivalents
$880M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$27M
+30.8%
Gross Profit
-$138M
-$130M
-6.3%
Operating Income
-$210M
-$190M
-10.5%
Net Income
-$169M
-$181M
+6.4%
← Q4 2023
All Quarters
Q1 2024 →